Millennium Research Group (MRG), the global authority on medical technology market intelligence, has completed a thorough analysis of the U.S. gynecological device market and found that physician and patient demand for minimally invasive gynecological devices will increase significantly over the next five years. Newer technologies, such as global endometrial ablation (GEA), transcervical sterilization, and uterine artery embolization (UAE) devices, appeal to physicians because of their minimally invasive nature and ease-of-use. According to the new report entitled U.S. Markets for Gynecological Devices 2007, the total market will grow rapidly, reaching over $700 million by 2011.
GEA will experience strong growth over the forecast period as clinical benefits such as ease-of-use and speed continue to drive gynecologists' rapid acceptance of this minimally invasive procedure. The high in-office reimbursement rates available for GEA procedures will also facilitate their gradual transition from hospitals into physician offices.
"In addition to GEA devices, transcervical sterilization devices and UAE devices will contribute to the growth of the gynecological device market," says Barbara Prud'homme, Senior Analyst at MRG. "These new technologies reduce postoperative recovery times and provide simpler and more convenient alternatives for patients who would otherwise require a hysterectomy to treat their uterine conditions."
MRG's U.S. Markets for Gynecological Devices 2007 report includes coverage of all key industry competitors, including Cytyc Corporation (CYTC), Gynecare, Boston Scientific (BSX), Conceptus (CPTS), Gyrus ACMI (GGYRF.PK), Cooper Surgical, American Medical Systems (AMMD), Microsulis, Karl Storz Endoscopy, Biosphere Medical (BSMD), Richard Wolf, Olympus, Davol, Irvine Scientific, Wallach Surgical Devices, Welch Allyn, Cook Medical, Vitrolife, Rocket Medical, Carl Zeiss, and Biocompatibles/Terumo.
About Gynecological Devices
The US gynecological device market consists of GEA devices, female sterilization devices, assisted reproduction consumables, colposcopes, fluid management devices, endometrial resection devices, hysteroscopes, and UAE devices.
About Millennium Research Group
Millennium Research Group (http://www.mrg.net/), a Decision Resources, Inc. company (http://www.decisionresources.com/), is a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 email@example.com
SOURCE: Millennium Research Group
CONTACT: Amy Krohn of Millennium Research Group, +1-416-364-7776 x101,